106 related articles for article (PubMed ID: 21761100)
1. EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact.
Li CF; Fang FM; Wang JM; Tzeng CC; Tai HC; Wei YC; Li SH; Lee YT; Wang YH; Yu SC; Shiue YL; Chu PY; Wang WL; Chen LT; Huang HY
Ann Surg Oncol; 2012 Feb; 19(2):443-54. PubMed ID: 21761100
[TBL] [Abstract][Full Text] [Related]
2. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
Zheng Y; Izumi K; Yao JL; Miyamoto H
Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of epidermal growth factor receptor and chromosome 7 polysomy in gastric adenocarcinoma.
Zhang F; Tang JM; Wang L; Shen JY; Zheng L; Wu PP; Zhang M; Yan ZW
J Dig Dis; 2012 Jul; 13(7):350-9. PubMed ID: 22713084
[TBL] [Abstract][Full Text] [Related]
4. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway.
Lo HW; Hsu SC; Ali-Seyed M; Gunduz M; Xia W; Wei Y; Bartholomeusz G; Shih JY; Hung MC
Cancer Cell; 2005 Jun; 7(6):575-89. PubMed ID: 15950906
[TBL] [Abstract][Full Text] [Related]
5. Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.
Hoshino M; Fukui H; Ono Y; Sekikawa A; Ichikawa K; Tomita S; Imai Y; Imura J; Hiraishi H; Fujimori T
Pathobiology; 2007; 74(1):15-21. PubMed ID: 17496429
[TBL] [Abstract][Full Text] [Related]
6. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted picture.
Thariat J; Etienne-Grimaldi MC; Grall D; Bensadoun RJ; Cayre A; Penault-Llorca F; Veracini L; Francoual M; Formento JL; Dassonville O; De Raucourt D; Geoffrois L; Giraud P; Racadot S; Morinière S; Milano G; Van Obberghen-Schilling E
Clin Cancer Res; 2012 Mar; 18(5):1313-22. PubMed ID: 22228639
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation status of epidermal growth factor receptor is closely associated with responsiveness to gefitinib in pulmonary adenocarcinoma.
Hijiya N; Miyawaki M; Kawahara K; Akamine S; Tsuji K; Kadota J; Akizuki S; Uchida T; Matsuura K; Tsukamoto Y; Moriyama M
Hum Pathol; 2008 Mar; 39(3):316-23. PubMed ID: 18261621
[TBL] [Abstract][Full Text] [Related]
9. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
10. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
11. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
Yan F; Hui YN; Li YJ; Guo CM; Meng H
Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer.
Noordhuis MG; Eijsink JJ; Ten Hoor KA; Roossink F; Hollema H; Arts HJ; Pras E; Maduro JH; Reyners AK; de Bock GH; Wisman GB; Schuuring E; van der Zee AG
Clin Cancer Res; 2009 Dec; 15(23):7389-97. PubMed ID: 19920104
[TBL] [Abstract][Full Text] [Related]
14. SLC37A1 gene expression is up-regulated by epidermal growth factor in breast cancer cells.
Iacopetta D; Lappano R; Cappello AR; Madeo M; De Francesco EM; Santoro A; Curcio R; Capobianco L; Pezzi V; Maggiolini M; Dolce V
Breast Cancer Res Treat; 2010 Aug; 122(3):755-64. PubMed ID: 19894109
[TBL] [Abstract][Full Text] [Related]
15. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
[TBL] [Abstract][Full Text] [Related]
16. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells.
Keates S; Keates AC; Katchar K; Peek RM; Kelly CP
J Infect Dis; 2007 Jul; 196(1):95-103. PubMed ID: 17538889
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of inducible nitric oxide synthase for human buccal squamous-cell carcinomas: immunohistochemical, reverse transcription-polymerase chain reaction (RT-PCR) and in situ RT-PCR studies.
Chen YK; Hsue SS; Lin LM
Head Neck; 2002 Oct; 24(10):925-32. PubMed ID: 12369071
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
20. Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.
Murakawa T; Tsuda H; Tanimoto T; Tanabe T; Kitahara S; Matsubara O
Pathol Int; 2005 Dec; 55(12):757-65. PubMed ID: 16287490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
